-
Loading metrics
TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects
- Gary J. Haderski,
- Bojidar M. Kandar,
- Craig M. Brackett,
- Ilia M. Toshkov,
- Christopher P. Johnson,
- Geraldine M. Paszkiewicz,
- Venkatesh Natarajan,
- Anatoli S. Gleiberman,
- Andrei V. Gudkov,
- Lyudmila G. Burdelya
x
- Published: February 6, 2020
- https://doi.org/10.1371/journal.pone.0227940